世界の組換えDNA技術市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Recombinant DNA Technology Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4956 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、組換えDNA技術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン、遺伝子組換え作物、特殊化学品）、用途別市場規模（バイオテクノロジー＆製薬会社、学術＆政府研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・組換えDNA技術の市場動向 ・企業の競争状況、市場シェア ・組換えDNA技術の種類別市場規模（治療薬、ワクチン、遺伝子組換え作物、特殊化学品） ・組換えDNA技術の用途別市場規模（バイオテクノロジー＆製薬会社、学術＆政府研究機関、その他） ・組換えDNA技術の北米市場規模2016-2027（アメリカ、カナダ） ・組換えDNA技術のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換えDNA技術のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換えDNA技術の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換えDNA技術の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Monsanto Company、Roche、Biogen、Amgen、Novartis、Eli Lilly and Company、GenScript、Pfizer Inc.、Novo Nordisk、Sanofi、Merck KGaA、Profacgen、Biocon、GlaxoSmithKline、Cibus、Horizon Discovery Group、New England Biolabs） ・結論

Market Analysis and Insights: Global Recombinant DNA Technology Market
The global Recombinant DNA Technology market size is projected to reach US$ 644 million by 2026, from US$ 490.8 million in 2019, at a CAGR of 3.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA Technology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA Technology market.

Global Recombinant DNA Technology Scope and Market Size
Recombinant DNA Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals

Segment by Application
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Amgen
Novartis
Profacgen
Biocon
GlaxoSmithKline
Cibus

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutic Agent
1.2.3 Vaccine
1.2.4 Biotech Crops
1.2.5 Specialty Chemicals
1.3 Market by Application
1.3.1 Global Recombinant DNA Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic & Government Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Recombinant DNA Technology Market Perspective (2016-2027)
2.2 Recombinant DNA Technology Growth Trends by Regions
2.2.1 Recombinant DNA Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant DNA Technology Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant DNA Technology Industry Dynamic
2.3.1 Recombinant DNA Technology Market Trends
2.3.2 Recombinant DNA Technology Market Drivers
2.3.3 Recombinant DNA Technology Market Challenges
2.3.4 Recombinant DNA Technology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA Technology Players by Revenue
3.1.1 Global Top Recombinant DNA Technology Players by Revenue (2016-2021)
3.1.2 Global Recombinant DNA Technology Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA Technology Revenue
3.4 Global Recombinant DNA Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA Technology Revenue in 2020
3.5 Recombinant DNA Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA Technology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant DNA Technology Breakdown Data by Type
4.1 Global Recombinant DNA Technology Historic Market Size by Type (2016-2021)
4.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027)

5 Recombinant DNA Technology Breakdown Data by Application
5.1 Global Recombinant DNA Technology Historic Market Size by Application (2016-2021)
5.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Recombinant DNA Technology Market Size (2016-2027)
6.2 North America Recombinant DNA Technology Market Size by Type
6.2.1 North America Recombinant DNA Technology Market Size by Type (2016-2021)
6.2.2 North America Recombinant DNA Technology Market Size by Type (2022-2027)
6.2.3 North America Recombinant DNA Technology Market Size by Type (2016-2027)
6.3 North America Recombinant DNA Technology Market Size by Application
6.3.1 North America Recombinant DNA Technology Market Size by Application (2016-2021)
6.3.2 North America Recombinant DNA Technology Market Size by Application (2022-2027)
6.3.3 North America Recombinant DNA Technology Market Size by Application (2016-2027)
6.4 North America Recombinant DNA Technology Market Size by Country
6.4.1 North America Recombinant DNA Technology Market Size by Country (2016-2021)
6.4.2 North America Recombinant DNA Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Recombinant DNA Technology Market Size (2016-2027)
7.2 Europe Recombinant DNA Technology Market Size by Type
7.2.1 Europe Recombinant DNA Technology Market Size by Type (2016-2021)
7.2.2 Europe Recombinant DNA Technology Market Size by Type (2022-2027)
7.2.3 Europe Recombinant DNA Technology Market Size by Type (2016-2027)
7.3 Europe Recombinant DNA Technology Market Size by Application
7.3.1 Europe Recombinant DNA Technology Market Size by Application (2016-2021)
7.3.2 Europe Recombinant DNA Technology Market Size by Application (2022-2027)
7.3.3 Europe Recombinant DNA Technology Market Size by Application (2016-2027)
7.4 Europe Recombinant DNA Technology Market Size by Country
7.4.1 Europe Recombinant DNA Technology Market Size by Country (2016-2021)
7.4.2 Europe Recombinant DNA Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA Technology Market Size (2016-2027)
8.2 Asia-Pacific Recombinant DNA Technology Market Size by Type
8.2.1 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant DNA Technology Market Size by Application
8.3.1 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant DNA Technology Market Size by Region
8.4.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Recombinant DNA Technology Market Size (2016-2027)
9.2 Latin America Recombinant DNA Technology Market Size by Type
9.2.1 Latin America Recombinant DNA Technology Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant DNA Technology Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant DNA Technology Market Size by Type (2016-2027)
9.3 Latin America Recombinant DNA Technology Market Size by Application
9.3.1 Latin America Recombinant DNA Technology Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant DNA Technology Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant DNA Technology Market Size by Application (2016-2027)
9.4 Latin America Recombinant DNA Technology Market Size by Country
9.4.1 Latin America Recombinant DNA Technology Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant DNA Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA Technology Market Size (2016-2027)
10.2 Middle East & Africa Recombinant DNA Technology Market Size by Type
10.2.1 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant DNA Technology Market Size by Application
10.3.1 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant DNA Technology Market Size by Country
10.4.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Monsanto Company
11.1.1 Monsanto Company Company Details
11.1.2 Monsanto Company Business Overview
11.1.3 Monsanto Company Recombinant DNA Technology Introduction
11.1.4 Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021)
11.1.5 Monsanto Company Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Recombinant DNA Technology Introduction
11.2.4 Roche Revenue in Recombinant DNA Technology Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Recombinant DNA Technology Introduction
11.3.4 Biogen Revenue in Recombinant DNA Technology Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Amgen
11.4.1 Amgen Company Details
11.4.2 Amgen Business Overview
11.4.3 Amgen Recombinant DNA Technology Introduction
11.4.4 Amgen Revenue in Recombinant DNA Technology Business (2016-2021)
11.4.5 Amgen Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Recombinant DNA Technology Introduction
11.5.4 Novartis Revenue in Recombinant DNA Technology Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Recombinant DNA Technology Introduction
11.6.4 Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021)
11.6.5 Eli Lilly and Company Recent Development
11.7 GenScript
11.7.1 GenScript Company Details
11.7.2 GenScript Business Overview
11.7.3 GenScript Recombinant DNA Technology Introduction
11.7.4 GenScript Revenue in Recombinant DNA Technology Business (2016-2021)
11.7.5 GenScript Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Recombinant DNA Technology Introduction
11.8.4 Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Recombinant DNA Technology Introduction
11.9.4 Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021)
11.9.5 Novo Nordisk Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Recombinant DNA Technology Introduction
11.10.4 Sanofi Revenue in Recombinant DNA Technology Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Details
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Recombinant DNA Technology Introduction
11.11.4 Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021)
11.11.5 Merck KGaA Recent Development
11.12 Profacgen
11.12.1 Profacgen Company Details
11.12.2 Profacgen Business Overview
11.12.3 Profacgen Recombinant DNA Technology Introduction
11.12.4 Profacgen Revenue in Recombinant DNA Technology Business (2016-2021)
11.12.5 Profacgen Recent Development
11.13 Biocon
11.13.1 Biocon Company Details
11.13.2 Biocon Business Overview
11.13.3 Biocon Recombinant DNA Technology Introduction
11.13.4 Biocon Revenue in Recombinant DNA Technology Business (2016-2021)
11.13.5 Biocon Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Recombinant DNA Technology Introduction
11.14.4 GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021)
11.14.5 GlaxoSmithKline Recent Development
11.15 Cibus
11.15.1 Cibus Company Details
11.15.2 Cibus Business Overview
11.15.3 Cibus Recombinant DNA Technology Introduction
11.15.4 Cibus Revenue in Recombinant DNA Technology Business (2016-2021)
11.15.5 Cibus Recent Development
11.16 Horizon Discovery Group
11.16.1 Horizon Discovery Group Company Details
11.16.2 Horizon Discovery Group Business Overview
11.16.3 Horizon Discovery Group Recombinant DNA Technology Introduction
11.16.4 Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021)
11.16.5 Horizon Discovery Group Recent Development
11.17 New England Biolabs
11.17.1 New England Biolabs Company Details
11.17.2 New England Biolabs Business Overview
11.17.3 New England Biolabs Recombinant DNA Technology Introduction
11.17.4 New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021)
11.17.5 New England Biolabs Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Recombinant DNA Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutic Agent
Table 3. Key Players of Vaccine
Table 4. Key Players of Biotech Crops
Table 5. Key Players of Specialty Chemicals
Table 6. Global Recombinant DNA Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Recombinant DNA Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Recombinant DNA Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Recombinant DNA Technology Market Share by Regions (2016-2021)
Table 10. Global Recombinant DNA Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Recombinant DNA Technology Market Share by Regions (2022-2027)
Table 12. Recombinant DNA Technology Market Trends
Table 13. Recombinant DNA Technology Market Drivers
Table 14. Recombinant DNA Technology Market Challenges
Table 15. Recombinant DNA Technology Market Restraints
Table 16. Global Recombinant DNA Technology Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Recombinant DNA Technology Market Share by Players (2016-2021)
Table 18. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020)
Table 19. Ranking of Global Top Recombinant DNA Technology Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Recombinant DNA Technology Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Recombinant DNA Technology Product Solution and Service
Table 23. Date of Enter into Recombinant DNA Technology Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021)
Table 27. Global Recombinant DNA Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Recombinant DNA Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Recombinant DNA Technology Revenue Market Share by Application (2016-2021)
Table 31. Global Recombinant DNA Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Recombinant DNA Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Recombinant DNA Technology Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Recombinant DNA Technology Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Recombinant DNA Technology Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Recombinant DNA Technology Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Recombinant DNA Technology Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Recombinant DNA Technology Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Recombinant DNA Technology Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Recombinant DNA Technology Market Size by Country (2022-2027) & (US$ Million)
Table 63. Monsanto Company Company Details
Table 64. Monsanto Company Business Overview
Table 65. Monsanto Company Recombinant DNA Technology Product
Table 66. Monsanto Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 67. Monsanto Company Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Recombinant DNA Technology Product
Table 71. Roche Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Biogen Company Details
Table 74. Biogen Business Overview
Table 75. Biogen Recombinant DNA Technology Product
Table 76. Biogen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 77. Biogen Recent Development
Table 78. Amgen Company Details
Table 79. Amgen Business Overview
Table 80. Amgen Recombinant DNA Technology Product
Table 81. Amgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 82. Amgen Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Recombinant DNA Technology Product
Table 86. Novartis Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Recombinant DNA Technology Product
Table 91. Eli Lilly and Company Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 92. Eli Lilly and Company Recent Development
Table 93. GenScript Company Details
Table 94. GenScript Business Overview
Table 95. GenScript Recombinant DNA Technology Product
Table 96. GenScript Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 97. GenScript Recent Development
Table 98. Pfizer Inc. Company Details
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 101. Pfizer Inc. Recent Development
Table 102. Novo Nordisk Company Details
Table 103. Novo Nordisk Business Overview
Table 104. Novo Nordisk Recombinant DNA Technology Product
Table 105. Novo Nordisk Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 106. Novo Nordisk Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Recombinant DNA Technology Product
Table 110. Sanofi Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 111. Sanofi Recent Development
Table 112. Merck KGaA Company Details
Table 113. Merck KGaA Business Overview
Table 114. Merck KGaA Recombinant DNA Technology Product
Table 115. Merck KGaA Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 116. Merck KGaA Recent Development
Table 117. Profacgen Company Details
Table 118. Profacgen Business Overview
Table 119. Profacgen Recombinant DNA Technology Product
Table 120. Profacgen Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 121. Profacgen Recent Development
Table 122. Biocon Company Details
Table 123. Biocon Business Overview
Table 124. Biocon Recombinant DNA Technology Product
Table 125. Biocon Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 126. Biocon Recent Development
Table 127. GlaxoSmithKline Company Details
Table 128. GlaxoSmithKline Business Overview
Table 129. GlaxoSmithKline Recombinant DNA Technology Product
Table 130. GlaxoSmithKline Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 131. GlaxoSmithKline Recent Development
Table 132. Cibus Company Details
Table 133. Cibus Business Overview
Table 134. Cibus Recombinant DNA Technology Product
Table 135. Cibus Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 136. Cibus Recent Development
Table 137. Horizon Discovery Group Company Details
Table 138. Horizon Discovery Group Business Overview
Table 139. Horizon Discovery Group Recombinant DNA Technology Product
Table 140. Horizon Discovery Group Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 141. Horizon Discovery Group Recent Development
Table 142. New England Biolabs Company Details
Table 143. New England Biolabs Business Overview
Table 144. New England Biolabs Recombinant DNA Technology Product
Table 145. New England Biolabs Revenue in Recombinant DNA Technology Business (2016-2021) & (US$ Million)
Table 146. New England Biolabs Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA Technology Market Share by Type: 2020 VS 2027
Figure 2. Therapeutic Agent Features
Figure 3. Vaccine Features
Figure 4. Biotech Crops Features
Figure 5. Specialty Chemicals Features
Figure 6. Global Recombinant DNA Technology Market Share by Application: 2020 VS 2027
Figure 7. Biotechnology and Pharmaceutical Companies Case Studies
Figure 8. Academic & Government Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Recombinant DNA Technology Report Years Considered
Figure 11. Global Recombinant DNA Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Recombinant DNA Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Recombinant DNA Technology Market Share by Regions: 2020 VS 2027
Figure 14. Global Recombinant DNA Technology Market Share by Regions (2022-2027)
Figure 15. Global Recombinant DNA Technology Market Share by Players in 2020
Figure 16. Global Top Recombinant DNA Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA Technology as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2020
Figure 18. Global Recombinant DNA Technology Revenue Market Share by Type (2016-2021)
Figure 19. Global Recombinant DNA Technology Revenue Market Share by Type (2022-2027)
Figure 20. North America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 22. North America Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 23. North America Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 24. United States Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 28. Europe Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 29. Europe Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 30. Germany Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Recombinant DNA Technology Market Share by Region (2016-2027)
Figure 40. China Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 48. Latin America Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 49. Latin America Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 50. Mexico Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Recombinant DNA Technology Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Recombinant DNA Technology Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Recombinant DNA Technology Market Share by Country (2016-2027)
Figure 56. Turkey Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Recombinant DNA Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Monsanto Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 62. Amgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 65. GenScript Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 67. Novo Nordisk Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 69. Merck KGaA Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 70. Profacgen Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 71. Biocon Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 72. GlaxoSmithKline Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 73. Cibus Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 74. Horizon Discovery Group Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 75. New England Biolabs Revenue Growth Rate in Recombinant DNA Technology Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---